Covidh Technologies Ltd
- Market Cap ₹ 65.2 Cr.
- Current Price ₹ 77.5
- High / Low ₹ 77.5 / 1.90
- Stock P/E
- Book Value ₹ -0.13
- Dividend Yield 0.00 %
- ROCE 19.0 %
- ROE %
- Face Value ₹ 10.0
Pros
- Promoter holding has increased by 55.1% over last quarter.
Cons
- Company has low interest coverage ratio.
- Promoter holding has decreased over last 3 years: -41.4%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 23.32 | 10.90 | 25.50 | 21.36 | 28.92 | 12.30 | 2.13 | 2.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.19 | |
| 23.14 | 10.28 | 25.14 | 20.92 | 28.46 | 11.98 | 2.19 | 0.19 | 0.11 | 0.11 | 0.09 | 0.13 | 0.53 | |
| Operating Profit | 0.18 | 0.62 | 0.36 | 0.44 | 0.46 | 0.32 | -0.06 | 1.94 | -0.11 | -0.11 | -0.09 | -0.13 | -0.34 |
| OPM % | 0.77% | 5.69% | 1.41% | 2.06% | 1.59% | 2.60% | -2.82% | 91.08% | -178.95% | ||||
| 0.00 | 0.00 | -12.61 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.27 | 0.28 | |
| Interest | 0.00 | 0.00 | 0.16 | 0.20 | 0.27 | 0.23 | 0.22 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.10 | 0.50 | 0.08 | 0.21 | 0.15 | 0.08 | 0.12 | 0.12 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.08 | 0.12 | -12.49 | 0.03 | 0.04 | 0.01 | -0.40 | 1.80 | -0.11 | -0.11 | -0.09 | 0.14 | -0.06 |
| Tax % | 50.00% | 0.00% | 0.40% | 100.00% | 25.00% | 200.00% | 5.00% | 1.11% | 0.00% | 0.00% | 0.00% | 0.00% | |
| 0.04 | 0.12 | -12.54 | 0.00 | 0.04 | -0.02 | -0.42 | 1.78 | -0.11 | -0.11 | -0.09 | 0.14 | -0.06 | |
| EPS in Rs | 0.00 | 0.00 | -0.46 | 0.00 | 0.00 | -0.00 | -0.02 | 0.06 | -0.00 | -0.00 | -0.11 | 0.17 | -0.07 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 2% |
| 5 Years: | 18% |
| 3 Years: | 48% |
| TTM: | 63% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 142% |
| 3 Years: | 252% |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10.60 | 10.60 | 10.60 | 10.60 | 10.60 | 10.60 | 10.60 | 10.60 | 0.30 | 0.30 | 0.32 | 0.32 | 0.32 |
| Reserves | 2.33 | 2.44 | -10.10 | -10.09 | -10.05 | -10.07 | -10.49 | -10.71 | -0.31 | -0.42 | -0.54 | -0.42 | -0.43 |
| 4.28 | 4.97 | 6.15 | 6.83 | 7.49 | 7.53 | 6.56 | 2.02 | 0.00 | 0.13 | 0.18 | 1.61 | 1.62 | |
| 3.56 | 2.54 | 4.61 | 5.57 | 8.19 | 4.12 | 3.81 | 2.59 | 0.02 | 0.04 | 0.10 | 0.05 | 0.04 | |
| Total Liabilities | 20.77 | 20.55 | 11.26 | 12.91 | 16.23 | 12.18 | 10.48 | 4.50 | 0.01 | 0.05 | 0.06 | 1.56 | 1.55 |
| 4.75 | 6.65 | 0.48 | 0.44 | 0.45 | 0.75 | 0.62 | 0.43 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CWIP | 3.08 | 1.96 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 4.32 | 4.20 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 8.62 | 7.74 | 10.78 | 12.47 | 15.78 | 11.43 | 9.86 | 4.07 | 0.01 | 0.05 | 0.06 | 1.56 | 1.55 | |
| Total Assets | 20.77 | 20.55 | 11.26 | 12.91 | 16.23 | 12.18 | 10.48 | 4.50 | 0.01 | 0.05 | 0.06 | 1.56 | 1.55 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.01 | 0.50 | 0.81 | -0.63 | -0.51 | 0.34 | 0.97 | 4.45 | -0.30 | -0.12 | -0.06 | -1.40 | |
| -0.05 | -1.16 | -0.40 | -0.16 | -0.16 | -0.38 | 0.00 | 0.10 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 3.02 | 0.69 | -0.42 | 0.77 | 0.66 | 0.04 | -0.97 | -4.55 | 0.30 | 0.13 | 0.06 | 1.42 | |
| Net Cash Flow | -0.04 | 0.04 | -0.01 | -0.02 | -0.01 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | 0.00 | 0.02 |
| Free Cash Flow | -3.02 | -0.78 | 0.41 | -0.79 | -0.67 | -0.04 | 0.97 | 4.55 | -0.30 | -0.12 | -0.06 | -1.40 |
| CFO/OP | -1,672% | 81% | 225% | -143% | -109% | 112% | -1,650% | 229% | 273% | 109% | 67% | 1,062% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 130.54 | 192.55 | 122.81 | 174.64 | 177.96 | 297.34 | 1,470.28 | 498.66 | ||||
| Inventory Days | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 130.54 | 192.55 | 122.81 | 174.64 | 177.96 | 297.34 | 1,470.28 | 498.66 | ||||
| Working Capital Days | 79.35 | 174.46 | 65.13 | 91.59 | 73.58 | 170.33 | 1,041.88 | 260.47 | ||||
| ROCE % | 0.51% | 0.68% | 2.27% | 3.29% | 4.03% | 2.98% | -2.44% | 42.42% | -11.58% | 19.05% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Remuneration (Salaries & Allowances) INR Lakhs |
|
|||||||||||
| Foreign Exchange Earnings (Exports) INR Lakhs |
||||||||||||
| IT/ITES Segment Contribution to Turnover % |
||||||||||||
| Gross Block - Products Developed INR Lakhs |
||||||||||||
| Products Under Development (CWIP) INR Lakhs |
||||||||||||
| Number of Shareholders Count |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Monitoring Agency Report For Utilization Of Proceeds Of Rights Issue Of Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited) For The Quarter Ended 31, March 2026.
1d - Submitted monitoring agency report for ₹8.08 crore rights issue; nil deviation for quarter ended March 31, 2026.
-
Isera Lifesciences Limited (Formerly Known As Covidh Technologies Limited)Has Filed With Exchange Monitoring Agency Report For Quarter Ended March 31, 2026.
1d - Monitoring agency report for Q4 FY2026 rights issue proceeds; deviation nil.
-
Board Meeting Intimation for Meeting Of The Board Of The Company Is Scheduled To Be Held On Thursday, May 21, 2026 To Consider, Approve And Take On Record The Audited Financial Results Of The Company For The Quarter And Year Ended On March 31, 2026
1d - Board meeting on 21 May 2026 to approve audited Q4 and FY2026 results; trading window closed from 1 April 2026.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
22 Apr - Submission of Newspaper Advertisement of Postal Ballot Notice pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015.
- Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 21 Apr
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
CTL is in the business of providing Information
Technology / Information Technology Enabled Services.